Form 4: NeueHealth Chief Accounting Officer Reports Stock Transaction

Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, Inc., reported the acquisition of 3,640 shares of common stock through the vesting of restricted stock units.

Summary

• Jeffrey J. Scherman, the Chief Accounting Officer of NeueHealth, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction on January 3, 2025, where 3,640 restricted stock units vested.
• Upon vesting, these units converted into 3,640 shares of NeueHealth common stock.
• Following the transaction, Mr. Scherman directly owns 7,310 shares of common stock.

Sentiment

Score: 7

Explanation: The document is a routine SEC filing related to insider transactions, which is neither positive nor negative. It is a neutral event that provides transparency.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the holdings of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for all publicly traded companies in the United States.
• The reporting of stock transactions by officers is a common occurrence and is required by the SEC to ensure transparency and prevent insider trading.
• The vesting of restricted stock units is a typical form of compensation for executives in many industries.

Stakeholder Impact

• This filing provides transparency to shareholders regarding the stock ownership of a key executive.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Transaction, Restricted Stock Units, Beneficial Ownership, NeueHealth, NEUE, Jeffrey J. Scherman, Chief Accounting Officer